| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Coave Therapeutics Coave therapeutics new brand for Horama Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet … Type: | 7 | 5 | 1 | 36 |
 |  BIOMEDICAL TISSUES Biomedical Tissues is specialised in the research and development of implantable medical devices for the regeneration of human tissue. We have invented a novel way to produce microfibers of synthetic biodegradable polymers which can be used as tissue regenerative guides. These devices mimic the structure of collagen fibers offering a 3D environment for cell colonization and proliferation for tissue healing. Our first product to market is Tisseos, a new resorbable synthetic membrane for dental implantology and periodontology. Biomedical Tissues also offers implantable biomaterial and medical device testing and evaluation services for cardiovascular, dental and orthopaedic implants, osteoinductive materials, tissue engineering … Type: | 1 | 1 | 0 | 2 |
 | Gravipack® [Automatic translation follows] This is not a backpack! GRAVIPACK: Revolutionary Innovation for Aerospace and Defense. Discover the exoskeleton that lightens the load on the shoulders and back, prevents musculoskeletal disorders and improves posture. Rewarded and recognized by prestigious institutions, GRAVIPACK is the essential solution for health and performance in the civil and military sectors. Carry more to go further! Innovation R&D French Tech, hiking, mountain sports, startup, backpack, ecommerce, revolutionary invention, revolutionary innovation, hiking sport, travel backpack, back pain backpack, travel backpack, lepine competition, errafi mohammed, gravipack innovation, disability, handisport, connected, and exoskeleton Type: | 35 | 1 | 34 | 4 |
 | Molsid Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel … Type: | 9 | 3 | 5 | 16 |
 | METHYS Dx Innovating for cancer patients METHYS Dx develops innovative liquid biopsy tests for non-invasive monitoring of cancer patients. Combining unique proprietary molecular signatures and a disruptive ultrasensitive detection technology, METHYS Dx tests will allow monitoring of tumor evolution, and early detection of relapses, thus improving patient care through better-informed therapeutic decisions. ctDNA, Cancer, Biomarqueurs, circulating tumoral DNA, Liquid biopsy, Precision medicine, and ddPCR Type: | 21 | 7 | 4 | 14 |
 | Cible Skin [Automatic translation follows] Expert in skin health and beauty Cible Skin is the alliance of medical expertise, cutting-edge technology and science, in order to preserve the health and beauty of all skin types. Instagram: https://www.instagram.com/cibleskin.paris/ Medical-cosmetic care and treatments for the face, body and hair, Sale of cosmeceuticals, Training of aesthetic doctors, and Aesthetic facial care Type: | 0 | 0 | 0 | 35 |
 |  Standing Ovation Where the wonders of fermentation meet science. Standing Ovation is a French protein company specializing in precision fermentation. The company has developed its first patented ingredient, Advanced Casein®, which is produced with 10 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, functional and taste qualities on par with the animal-sourced protein. Standing Ovation will launch its flagship protein in the United States in 2025 and aims to be a global leader in the food and environmental transition. As a winner of the French Tech 2030 program, Standing Ovation has received government … Tags: FrenchTech2030 Type: | 34 | 9 | 26 | 38 |
 | Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … Type: | 4 | 3 | 0 | 1 |
 | AIXIAL GROUP Bringing reliability and expertise to clinical development Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing Biometrics and Clinical Research, … Type: | 2 | 1 | 1 | 748 |
 |  Genbiotech Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For … Type: | 1 | 1 | 0 | 8 |
 | CERTIS Therapeutics Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation Type: | 3 | 3 | 0 | 14 |
 | Gecko Biomedical Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients. Type: | 0 | 0 | 0 | 4 |
 | OMEDIT Ile-de-France [Automatic translation follows] The Observatory of Medicines 💊, Medical Devices 💉 and Therapeutic Innovation 🔬🧬 OMEDIT Ile-de-France is a regional support structure in the field of Medicines, Medical Devices and Therapeutic Innovation. Type: | 12 | 1 | 10 | 10 |
 | IDMED Innovative technology, safer outcomes. IDMED, a French company based in Marseille, develops and markets innovative medical devices in the fields of anesthesia and intensive care. Our products are used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations and research laboratories. Our products are commonly used in the areas of pupillometry, neuromuscular blockade monitoring and analgesia monitoring. IDMED develops products in collaboration with healthcare professionals. Innovation, reliability and relevance are the core qualities of our devices. We put our technical knowledge to the service of an improved everyday clinical practice. Healthcare, Medical device, Anaesthesiology, Medical technology, ICU, Pupillometry, and Analgesia … Type: | 4 | 3 | 2 | 24 |
 | NH TherAguix Nanomedicine For Precision Radiotherapy NH TherAguix , a Phase 2 biotech company, has developed an innovative nano drug AGuIX® to improve cancer treatment by radiotherapy to treat tumours and metastases. Its pharmacological properties and its mode of action by bio-distribution allow it to act in the heart of tumors and confer it a pan-cancer potential. AGuIX® is currently assessed in 4 Phase II randomized trials in brain metastases using either whole brain radiation therapy (NANORAD2, CHUGA, Grenoble, France) or stereo-radiosurgery (NANOBRAINMETS, Dana Farber Brigham Cancer Center, Boston, USA), in glioblastoma (NANOGBM, multicentric, Clermont Ferrand, France) as well as in pancreatic … Type: | 8 | 7 | 1 | 21 |
 | Neocor Therapeutics Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology Type: | 1 | 0 | 0 | 4 |
 | ElyssaMed SAS ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction. Type: | 4 | 4 | 0 | 2 |
 | KALSIOM SAS Targeting calcium signaling to cure auto-immune diseases KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes. Immunology and Therapeutic antibodies Type: | 5 | 3 | 1 | 5 |
 | eVeDrug [Automatic translation follows] eVeDrug calls upon various stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and who draw on their experience acquired both from industrial circles (laboratories and manufacturers) and institutional circles (health authorities from different countries). Above all, eVeDrug wishes to restore trust between patients and their health system by placing the main person concerned (the patient himself) at the center of the health system responsible for protecting him. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) who … Type: | 18 | 2 | 10 | 6 |
 | NeoMedLight The Caring Light NeoMedLight develops innovative medical devices designed for phototherapy. The company owns a unique and exclusive technology: the emission of light through woven optical fibers: the Lightex®. NeoMedLight is committed to the treatment and prevention of oral mucositis and radiodermatitis, a huge unmet clinical need. Mucositis and radiodermatitis are the most common and debilitating side effects of chemotherapy and radiotherapy reported by cancer patients. CareMin650TM is an innovative solution leveraging our innovative Lightex® technology indicated for the prevention and treatment of mucositis and dermatitis in cancer patients. The CareMin650TM system allows patients to be treated safely, with precise … Type: | 3 | 1 | 1 | 9 |
 | Eomaia [Automatic translation follows] Supporting the donation of colostrum from mother to premature child Eomaia is a start-up created in 2022 that designs a medical device to express colostrum in a hospital environment. Colostrum is an infinitely precious immune concentrate for children born prematurely. Often unable to breastfeed, only manual expression of colostrum allows young mothers to collect this "liquid gold" for their infant. However, subject to many obstacles due to a painful artisanal practice, many premature children are unfortunately deprived of it. Eomaia wishes to facilitate the practice of manual expression of colostrum during the maternity stay by offering a … Type: | 11 | 2 | 10 | 1 |
 | Planktovie Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number … Type: | 11 | 2 | 8 | 4 |
 | BioIntrant [Automatic translation follows] Probiotic Agriculture: Improving Agricultural Productivity Through Plant Health BioIntrant integrates more than thirty years of research at the interface of agronomy, pedology, microbial ecology and bioinformatics, in order to develop biostimulants for modern and responsible agriculture. To do this, BioIntrant integrates the plant into its environment (plant triptych, soil structure, microorganisms) to promote its intrinsic ability to defend itself. It is now possible, thanks to the most advanced technologies and knowledge of the microbial ecology of plants, to restore this natural balance. Biotechnology, Agriculture, Agronomy, Microbiology, Biostimulant, Bioinformatics, and Genomics Type: | 12 | 2 | 11 | 4 |
 | Dyameo [Automatic translation follows] Dyameo is a research & development company in the field of medical devices that designs probes to help diagnose cancer cells in vivo. This medical device allows to answer the question: "Are these cells cancerous?", and this in a simple, clear and instantaneous way. This breakthrough solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, MedTech, and Aid to in-vivo cancer diagnosis Type: | 2 | 2 | 0 | 9 |
 | Five Lives Add Life to Years. We build Digital Therapeutics for better risk assessment & prevention of dementia. Five Lives is a Digital Therapeutics start-up developing “Five Lives”, a direct-to-consumer brain health mobile app to help everyone measure and reduce their risk of dementia through an improved lifestyle. Type: | 14 | 7 | 8 | 22 |
 | BILHI Genetics The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases. To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands … Type: | 1 | 1 | 1 | 5 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish Type: | 4 | 3 | 1 | 5 |
 | NFL BIOSCIENCES Two Simple Injections for Total Smoking Cessation NFL BIOSCIENCES clinically develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. It is delivered via two simple subcutaneous injections, administered one week apart, making patient compliance a breeze. There exists vast anecdotal evidence, from more than 10,000 smokers treated off-label in France with a predecessor product developed by the Pasteur Institute, that NFL-101 is safe and efficacious for total smoking cessation at twelve months. A Phase 1 clinical trial that reported data in 2017 confirmed safety and efficacy in smokers willing … Type: | 0 | 0 | 0 | 8 |
 | Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Type: | 7 | 6 | 1 | 33 |
 | Seenel Imaging Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research. Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market. NIRS, EEG, Brain Imaging, Functional NIRS, Cognitive Research, Optical Imaging, Innovation, and Neuroscience Type: | 2 | 2 | 0 | 8 |
 | ScreenCell Isolating CTCs has never been so simple. ScreenCell was set-up with the belief that just enumerating Circulating Tumor Cells (CTCs) without easily characterizing them was not enough to allow the early detection of a disease and to potentially follow-up the cancer progression. So it designed and produced a simple but revolutionary technology allowing the fast and effective isolation of CTCs for a better cellular and molecular characterization, which is essential in cancer monitoring. This technology also contributes to the development of a new non-invasive approach to prenatal diagnosis. Screencell is dedicated to create technologies allowing CTC to become potential end … Type: | 2 | 0 | 2 | 18 |
 | Fizimed A powerful way to women's healthcare A pioneer in FemTech and HealthCare, Fizimed develops innovative, connected medical devices that make it easy to take control of your health at home. Type: | 23 | 12 | 5 | 20 |
 | SYNOVANCE Engineering a Sustainable Future We are a strain development company. We engineer purpose-built secondary genomes that facilitate the bio-production of high value chemicals and enzymes. Inline with the circular economy, we are currently establishing a biorefinery that uses second generation sustainable feedstocks for fermentations. Biotechnology, Genome Engineering, Synthetic Biology, pigments, and fermentation Type: | 12 | 4 | 10 | 13 |
 | PhysioAssist [Automatic translation follows] PhysioAssist develops and markets Simeox, an innovative airway clearance device for patients with CF, COPD, BE PhysioAssist is a medical equipment company that has developed expertise in rheology, the study of the physics of bronchial mucus. After several years of research, an effective pneumatic vibration signal has been characterized to act on intrapulmonary mucus, liquefy it and drain it. This signal is delivered by the Simeox medical device, which stimulates bronchial mucus by successive depressions, while ensuring passive expiration. Simeox is intended for patients with chronic respiratory diseases. COPD, airway clearance, respiratory device, and cystic fibrosis Type: | 6 | 4 | 0 | 16 |
 | CEMENTIC Nano-Life Innovations Cementic, founded in 2016, is a pioneering biotech startup with bases in Paris, France, and Palo Alto, USA. Specializing in cutting-edge nano-biotechnology solutions, our focus is on revolutionizing healthcare through innovative applications in dental care, orthopedics, and stem cell research. We leverage new paradigms to address complex health challenges, advancing global health from our dual locations. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes Type: | 0 | 0 | 0 | 3 |
 | Suricog SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The … Type: | 2 | 4 | 0 | 18 |
 | Perha Pharmaceuticals From Sea to Pharmacy Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man. Perha Pharma focuses its research on two main diseases: cognitive disorders associated with Down syndrome (DS) and Alzheimer’s disease (AD), and hearing loss (HL) induced by ototoxic products. The first proof-of-concept in man should be achieved in both pathologies through niche indications: cognitive deficits in DS and hearing loss induced by cis-platin or aminoglycoside antibiotics. Perha Pharma was co-founded in April 2019 by Dr Laurent MEIJER, Chairman & CSO, former distinguished Director … Type: | 5 | 5 | 0 | 12 |
 | CTIBiotech Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … Type: | 19 | 2 | 15 | 22 |
 | Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production … Type: | 3 | 0 | 3 | 1 |
 | Pomega Laboratories New Natural & Ethical Anti Inflammatory Pharmaceutical Products Natural Products with Proven Health Claims For PETS. Pomega develops a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage. Product is developed by skilled pharmacist under drug standards frame First product coming out the pipeline is Ω-344 Product , a patented fruit extract with strong anti inflammatory properties osteoarthritis , anti inflammatory, fruit extract, inflammation, arthritis, biotech, NSAIDs, pain, animal, dogs, pets, wellness, healthcare, petfood, and cats Type: | 1 | 1 | 0 | N/A |
 | Sirius NeoSight [Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company whose ambition is to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic efficacy implemented. Sirius NeoSight uses a patented breakthrough technology from a consortium of academic laboratories that are experts in the field. Type: | 17 | 6 | 6 | 4 |
 | SYNEIKA Treatment of chronic pathologies by non-invasive neurostimulation Manufacturer of neuronavigators for TMS, Syneika offers therapeutic solutions to alleviate chronic neurological and psychiatric diseases using a non-invasive neurostimulation technique: neuronavigated Transcranial Magnetic Stimulation (TMS). Syneika One, the neuronavigator designed by Syneika, was developed in collaboration with doctors and nurses. It is a fully integrated neuronavigator offering precision and ease of use in daily work. Syneika One neuronavigation for TMS aims to make repetitive Transcranial Magnetic Stimulation therapy accessible to any care team. It has been designed to fit the time constraints of an intensive therapeutic activity. To this end, powerful algorithms … Type: | 4 | 1 | 3 | 6 |
 | ALPHANOSOS OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … Type: | 4 | 3 | 1 | 4 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTx is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Non-opioid, locally acting ATX01 is designed to treat the pain of Chemotherapy-Induced Peripheral Neuropathy, a common and painful side-effect of cancer treatments. It targets the signaling pathways involved in the regulation of pain by selectively inhibiting specific nociceptive sodium channel receptors. FDA granted ATX01 Fast-Track designation. The ACT study is an international Phase II randomized, placebo-controlled trial involving over 270 patients ; The results will be available in early 2025 and the company is making … Type: | 4 | 3 | 2 | 12 |
 | IOME BIO Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology Cancer continues to be a leading cause of disability and early mortality worldwide. Immune checkpoint blockade with PD/L-1 therapies such as Keytruda and Opdivo can induce complete and durable clinical responses in multiple tumors, a breakthrough in cancer treatment over the last decade. However, only around 20% of patients respond and many trials have failed Many R&D programs in multiple companies are attempting to improve the clinical efficacy of PD/L-1 therapies, but no solution is yet approved. Most of these approaches target T-cells or the tumour microenvironment. Patients with … Type: | 5 | 2 | 4 | 4 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: | 2 | 2 | 0 | 16 |
 | myaddie My Addie creates digital solutions that help people live with their addictions on a daily basis. Addiction is a reality that reaches out everyone, from sugar to drugs, from sports to shopping, nowadays, we are all addicted to something, and.. that's fine. The question is, what do we do about it ? This is why we at My Addie have created a unique methodolgy created by an addict, for addicts, backed up by the latest neuroscience, and a solid team of therapists. My addie strongly believes that it is time to put people back at the center of their journeys, … Type: | 3 | 1 | 2 | 2 |
 | Winback Game Ready France [Automatic translation follows] Innovative Therapeutic Solutions - Winback Technology - Exclusive Game Ready Distributor in France In 2013, Winback was created on the innovative idea of combining for the first time clinical assessment, manual & physical therapy and physiotherapy, all in the same treatment. The combination of the unique expertise of each therapist and the revolutionary Winback technology has given birth to a new era of therapy. It allows therapists to provide more effective and faster treatments while offering a pleasant experience to patients. Winback is now present in 59 countries through 75 distributors, with more than 7,500 BACK systems … Type: | 1 | 1 | 1 | 93 |
 | Occentis Occentis is a drug discovery and development company, focusing on Autism, Alcohol and Opioid addiction and Pain. Occentis is a drug discovery and development company, focusing on mental health, with a groundbreaking approach backed by over two decades of extensive research conducted at the renowned French National Center for Scientific Research (CNRS) under the guidance of Professor Marcel Hibert, a distinguished figure in medicinal chemistry. Our mission is to revolutionise the treatment landscape for neuropsychiatric and neurobehavioral conditions, addressing significant unmet needs in therapeutic areas such as Autism, Alcohol and Opioid addiction, Pain and other conditions. In close collaboration with … Type: | 3 | 2 | 0 | N/A |
 | LABORATOIRES AXAMED SA [Automatic translation follows] HealthCare Innovation Partner Based in Paris, Laboratoires AXAMED®, have a strong capacity for innovation, specializing in the design, development, and marketing of innovative health products in the vast field of family health, electronic self-diagnosis for medical use, prevention and treatment of pain, family hygiene, well-being, as well as innovative food supplements sold under the NovaBoost® brand. The innovative medical products and devices designed by Laboratoires AXAMED® integrate technology and design and are focused on needs and uses. Laboratoires AXAMED® products provide comfort of use and well-being for patients/users. health, medical devices, prevention and treatment of pain, pharmaceutical, … Type: | 0 | 0 | 0 | 14 |
 | CYTOO CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health Type: | 2 | 1 | 0 | 35 |
 | Edonia Unlocking microalgae potential Unlocking microalgae potential ● EIT Food Seedbed Incubator (2023 Cohort) ● "Deeptech" certified by French Public Investment Bank (BPI) #microalgae #alternativeprotein Type: | 17 | 9 | 9 | 18 |
 | SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … Type: | 16 | 5 | 12 | 9 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … Type: | 11 | 3 | 9 | 6 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 27 | 8 | 22 | 14 |
 | NEURO-SYS CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s … Type: | 0 | 0 | 0 | 34 |
 | ErgoSanté ERGONOMICS FOR ALL ErgoSanté is a company specialized in the design, manufacturing, and distribution of customized ergonomic solutions aimed at maintaining employment for workers with disabilities and preventing musculoskeletal disorders (MSDs) risks. ErgoSanté distributes its products both nationally and worldwide. Our approach is unique: once your needs have been identified by healthcare professionals (such as occupational physicians, ergonomists, or employment support advisors), we lend you the recommended equipment for free so that you can judge the effectiveness of the proposed solution for yourself. We cater to both seated employees (with ergonomic chairs, height-adjustable desks, and accessories) and standing employees (with … Type: | 67 | 10 | 56 | 158 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 20 | 6 | 17 | 86 |
 | FasTeesH [Automatic translation follows] HesY, a medical device for effective dental brushing in 10 seconds for healthcare and accommodation establishments 📢📢📢Our consumer product, Y-Brush, is available now: http://ow.ly/DMal30luqQK 🚀🚀🚀 FasTeesH is a Lyon startup developing a "toothbrush of the future" that cleans all teeth simultaneously, simply and effectively, in just 10 seconds. Why? Few people like brushing their teeth. This daily task is therefore often "badly" and/or "quickly" done. This can lead to health problems, sometimes very serious. How? Currently, we brush only 1 side of 1 tooth at a time. Our innovation allows us to brush 16 complete teeth simultaneously … Type: | 2 | 2 | 0 | 2 |
 | Hilum Healthcare Not your grandpa's Medtech The story of aerospace engineers who aim at building top-notch medical devices. Type: | 16 | 0 | 13 | 11 |
 | Kejako Keep your Eyes Young Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which … Type: | 6 | 2 | 4 | 6 |
 | ECHODIA ECHODIA offers a wide range of devices specifically adapted to ENT doctors and other healthcare professsionals ECHODIA is a company created in 2009 specialized in hearing assessment in the fields of otorhinolaryngology and neuroscience. It develops and markets several devices dedicated to auditory measurements, specifically adapted to ENT doctors and other healthcare professionals’ needs (hearing care professionals, school nurses, occupational doctors, hospitals, etc.). ECHODIA offers a wide range of screening and diagnostic devices made in France so that you can perform all your hearing tests. ENT, HEARING, MEDICAL DEVICES, OCCUPATION HEALTH, SCREENING, AUDIOMETRY, ABR, TEOAE, MENIERE DISEASE, OCCUPATIONAL MEDICINE, OTOACOUSTICS … Type: | 1 | 0 | 0 | 6 |
 | Advesya Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune Type: | 7 | 2 | 1 | 24 |
 | ECLEVAR Your smart way to compliance As a CRO, we help our customers provide patients with safe and effective medical devices through solutions tailored to their business and regulatory challenges. OUR VALUES Trust and quality are the hallmarks of the way we work and partner with our clients. OUR MISSION We help our clients provide patients with safe and effective medical devices. OUR VISION Cost effectiveness, time savings and management of regulatory constraints. Regulatory evolutions differ from one region to another: they have their own rules and requirements for medical devices. It is crucial to partner with a CRO that understands … Type: | 1 | 1 | 0 | 35 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. Type: | 2 | 2 | 0 | 9 |
 | 3-D Matrix EMEA 3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical … Type: | 1 | 0 | 0 | 49 |
 | Biothelis [Automatic translation follows] Predicting respiratory distress BIOTHELIS develops and markets the ENDOMARK H1A medical device to predict the occurrence of severe respiratory distress in patients admitted to intensive care. Applicable to COVID-19 pneumonia, it optimizes patient care and improves prognosis. Type: | 1 | 0 | 0 | 2 |
 | ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … Type: | 1 | 1 | 0 | 10 |
 | Zippyware [Automatic translation follows] "Health - Education - Digital": this is Zippyware's leitmotif. Our mission? To ensure that each of us becomes an actor in our health through interactive solutions. At Zippyware, we are convinced of the need for prevention in public health and the major role of therapeutic education, particularly through multimedia supports. The digital transformation creates tremendous opportunities to allow as many people as possible to become actors in their health. Thanks to our unique combination of medical, educational and technological skills, Zippyware offers fun, innovative, efficient e-health solutions that meet the specific needs of users. Our tools can … Type: | 1 | 1 | 1 | 0 |
 | NETRIS Pharma Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group. Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center. Type: | 1 | 1 | 0 | 19 |
 | BIOMNIGENE Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - … Type: | 3 | 3 | 2 | 7 |
 | LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue Type: | 7 | 7 | 1 | 11 |
 | Jalon Therapeutics Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Our mission is to develop medicines that will transform the lives of people fighting cancer. For that purpose, we leverage our deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. This mechanism, defined as “non-oncogene addiction” (NOA), offers potential novel, safer and more effective therapeutic strategies. Jalon Therapeutics is rooted in pioneering fundamental research and clinical investigations from INSERM laboratories … Type: | 1 | 1 | 0 | 3 |
 | CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: | 31 | 17 | 23 | 100 |
 | Priothera SAS Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Type: | 12 | 2 | 2 | 21 |
 | Carthera Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical … Type: | 31 | 11 | 20 | 29 |
 | Cure51 We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus … Type: | 6 | 4 | 2 | 29 |
 | Push4m [Automatic translation follows] Smart muscles for robotics & exoskeletons Created in 2016, Push4m is a deeptech company that patented, after 5 years of R&D, the biomimetic muscle, a component that imitates the swelling of human muscle and dramatically improves the efficiency of exoskeletons and robots/cobots. This new generation universal actuator allows self-adaptation to the resistant torque by multiplying the engine torque or its speed. Through this slow, it allows the robotic machine to adapt to its environment and to the operator, in complete safety. And not the other way around as is currently the case. This considerably reduces the energy … Type: | 6 | 2 | 4 | 1 |
 | StromaCare Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody Type: | 4 | 3 | 2 | 16 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 24 | 12 | 14 | 36 |
 | SpineGuard Securing Implant Placement Making Spine Surgery Safer SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only … Type: | 1 | 0 | 1 | 29 |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 13 | 11 | 3 | 4 |
 | Arbiom Excellence in protein Arbiom is committed to feeding the world in a sustainable and healthy way. We are mastering the feedstock flexibility, to create the next generation of fermentation products and technologies. We are able to deliver high-quality and sustainable protein ingredients by tapping into nature-based solutions. Arbiom has created two protein-rich ingredients: SylPro for feed with high protein content, excellent digestibility and outstanding palatability suitable for petfood and feed nutrition; Yusto for food which bring quality, taste and well-being to nourrish people sustainably through meat and dairy analogs and specialized nutrition. Arbiom is now focusing on its industrial deployment, … Type: | 16 | 6 | 10 | 23 |
 | NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. Type: | 1 | 1 | 0 | 9 |
 | Biossan your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale Type: | 1 | 1 | 0 | 1 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 10 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 43 | 12 | 39 | 43 |
 | Neuroservices-Alliance The CNS Electrophysiology CRO - We provide decision-making data from functional endpoints for CNS & Pain drug discovery. Neuroservices-Alliance: The CNS Electrophysiology CRO. . Our mission Neuroservices-Alliance is a Global CNS Contract Research Organization (CRO) for translational data. We are committed to provide the Pharmaceutical Industry with state-of-the-art neuro-pharmacological functional endpoints, helping them accelerate their CNS and Pain drug discovery programs. . Our expertise Empowered by a strong college of experts, our integrated functional data from Rodent, Dog, Cyno and Human tissues accelerate CNS and Pain research programs thanks to fast and robust lead selection & optimization, investigation of MOA, … Type: | 10 | 2 | 9 | 23 |
 | Immusmol Immusmol develops small molecule antibodies for research, diagnostics and therapy. Combining 25 years of experience in antigen design, we offer to target low molecular weight molecules, which are not usually addressed by antibodies, such as amino acid metabolites, lipids, saccharids, toxins, pesticide residues, small molecule drugs, ... Compatible with existing antibody-based technologies, our small molecule antibodies can serve for: > VISUALIZATION: Small molecule antibodies currently represent the only applicable technology for the visualization of small molecules in cells and tissues by IF or IHC. > QUANTIFICATION: Combined with ELISA/EIA technologies, small molecule antibodies enable rapid and robust detection of small … Type: | 1 | 1 | 0 | 10 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 11 | 6 | 6 | 34 |
 | FineHeart A Healthier Life With Every Beat FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER®, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The … Type: | 29 | 11 | 24 | 72 |
 | X-PRESSURE Better measure CSF pressure at bedside X-Pressure est un dispositif médical innovant pour la mesure automatique et instantanée de la pression du liquide cérébro-spinal (LCS). La mesure de pression du LCS est historiquement réalisée par l’étude de la colonne d'eau au bout d’une aiguille de ponction lombaire (PL). Cette mesure est longue, imprécise et ne permet pas de détecter d’éventuelles anomalies. Or, une pression anormale peut avoir des conséquences graves pour le cerveau. X-Pressure développe un nouveau dispositif médical simple et précis pour mesurer la pression du LCS au lit du patient. Grâce à un système simple et connecté, le … Type: | 3 | 1 | 2 | 7 |
 | MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of extracting metals specifically, quickly and in a controlled manner. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: | 12 | 2 | 3 | 13 |
 | WhiteLab Genomics Unleash the Potential Of Genomic Medicine Using AI Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development timelines and mitigate associated risks. Based on exhaustive datasets, the platform provides in-silico simulations to discover, and design optimized payloads and vectors. WhiteLab aims to expedite the drug development process, cut costs, and accelerate the delivery of life-saving therapies to the market. The company collaborates with leading pharmaceutical companies such … Tags: FrenchTech2030 Type: | 44 | 15 | 33 | 43 |
 | Unooc [Automatic translation follows] The ambition of the Unooc.fr site is to support pharmacists on the Internet and to guarantee Internet users a purchase in a French pharmacy approved by the government. + For pharmacists: increased visibility, geolocation, highlighting of their advice and offers. + For French people: buy safely and at the best price. In one click, Unooc allows you to find: - Medicines, - Homeopathy, - Beauty products, - Baby products, etc. More than 50,000 references among around fifty partner French pharmacies. http://www.Unooc.fr/ Health, Internet, E-Commerce, and Search engine Type: | 3 | 2 | 0 | 1 |
 | ADEXSOL Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your … Type: | 5 | 0 | 3 | 2 |
 | Next Neurotech Innovative neurosurgical technologies for epilepsy. NxNeuro is developing technologies to treat patients suffering from refractory epilepsy. These are epilepsies that cannot be treated by drugs, leaving 4,800,000 patients in a therapeutic impasse. Thanks to our patented technologies, we help healthcare professionals to better manage these patients suffering from severe epilepsies. 🏥 NxNeuro medical devices enable more effective diagnosis and treatment, offering the chance of a cure to as many people as possible. Our goals: to treat more, to treat better, to treat without waiting, to give disease no chance. 🧠⚕️ If you too would like to join us in the … Type: | 6 | 4 | 2 | 2 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Beverages, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine plant-based salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance, texture, nutritional quality and also price. This patented product developed in partnership with specialized laboratories is … Type: | 3 | 2 | 0 | 2 |
 | Ciloa SAS Inspired by Exosomes CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high-potential bio-drugs. By overcoming undruggable targets, Ciloa supports your projects to create new therapeutic and new preventive solutions. Ciloa customizes in vivo exosomes to contain i) fully native membrane protein complexes (GPCRs, Kinase Receptors, Ion Channels, Viral Antigens, Transporters...) embedded in their membrane and ii) chosen cargo proteins inside their cytosol. Natural properties of exosomes combined with Ciloa in vivo disruptive technology allow to develop: - VIRUS-FREE candidate THERAPEUTIC VECTORS able to deliver specifically chosen cargos to … Type: | 3 | 3 | 0 | 10 |
 | ABL Diagnostics S.A [Automatic translation follows] Improving Diseases Management Founded in 2015, ABL DIAGNOSTICS designs, develops, manufactures, markets and supports in France and internationally, directly or via a network of exclusive distributors in 45 countries, molecular biology diagnostic tests for detection (UltraGene®) and genotyping by DNA sequencing (DeepChek®), for infectious diseases. These are the result of proprietary know-how acquired over the years and scientific collaborations with renowned teams and dedicated technical protocols. ABL DIAGNOSTICS has particularly developed high-tech medical genotyping devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and also for the genotyping of SARS-CoV-2 (Covid-19), as well as other … Type: | 1 | 1 | 0 | 21 |
Startup